The Use of Low Molecular Weight Heparin and Pneumatic Compression Devises for Deep Vein Thrombosis Prophylaxis in Major Trauma Patients: A Comparative Effectiveness Analysis

被引：0
|
作者：
Alahmari, Abdullah [1 ]
Almalki, Ziyad [1 ]
Jeff, Guo [1 ]
机构：
[1] Univ Cincinnati, Hlth Res Outcomes, Cincinnati, OH USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
627
引用
收藏
页码：358 / 359
页数：2
相关论文
共 50 条
  • [1] THE USE OF LOW MOLECULAR WEIGHT HEPARIN AND PNEUMATIC COMPRESSION DEVISES FOR DEEP VEIN THROMBOSIS PROPHYLAXIS IN MAJOR TRAUMA PATIENTS: A COMPARATIVE EFFECTIVENESS ANALYSIS
    Alahmari, A. K.
    Almalki, Z. S.
    Guo, J. J.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A132 - A132
  • [2] DEEP-VEIN THROMBOSIS PROPHYLAXIS AND LOW-MOLECULAR-WEIGHT HEPARIN
    VALLANO, A
    ARNAU, JM
    VALLES, JA
    [J]. MEDICINA CLINICA, 1991, 97 (07): : 272 - 275
  • [3] Clinical effectiveness of a pneumatic compression device combined with low-molecular-weight heparin for the prevention of deep vein thrombosis in trauma patients: A single-center retrospective cohort study
    Peng-chao Guo
    Nan Li
    Hui-ming Zhong
    Guang-feng Zhao
    [J]. World Journal of Emergency Medicine, 2022, 13 (03) : 189 - 195
  • [4] Clinical effectiveness of a pneumatic compression device combined with low-molecular-weight heparin for the prevention of deep vein thrombosis in trauma patients: A single-center retrospective cohort study
    Guo, Peng-chao
    Li, Nan
    Zhong, Hui-ming
    Zhao, Guang-feng
    [J]. WORLD JOURNAL OF EMERGENCY MEDICINE, 2022, 13 (03) : 189 - 195
  • [5] Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery
    De, Anushtup
    Roy, Prabal
    Garg, Vinod K.
    Pandey, Narendra K.
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (01) : 57 - 61
  • [6] Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis
    Shorr, Andrew F.
    Jackson, William L.
    Weiss, Brendan M.
    Moores, Lisa K.
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2007, 18 (04) : 309 - 316
  • [7] Low molecular weight heparin for deep vein thrombosis in glioma patients
    Schmidt, F
    Faul, C
    Dichgans, J
    Weller, M
    [J]. JOURNAL OF NEUROLOGY, 2002, 249 (10) : 1409 - 1412
  • [8] Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: Results from a cost-effectiveness analysis
    Shorr, AF
    Jackson, WL
    Weiss, BM
    Moores, LK
    [J]. CHEST, 2005, 128 (04) : 192S - 193S
  • [9] Low molecular weight heparin for deep vein thrombosis in glioma patients
    Friederike Schmidt
    Christoph Faul
    Johannes Dichgans
    Michael Weller
    [J]. Journal of Neurology, 2002, 249 : 1409 - 1412
  • [10] Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis
    Lopaciuk, S
    Bielska-Falda, H
    Noszczyk, W
    Bielawiec, M
    Witkiewicz, W
    Filipecki, S
    Michalak, J
    Ciesielski, L
    Mackiewicz, Z
    Czestochowska, E
    Zawilska, K
    Cencora, A
    Tomkowski, WZ
    Hajduk, B
    Kloczko, J
    Mazgajska, K
    Jaromin, J
    Chmielecki, Z
    Niedziela, P
    Czekalski, P
    Molski, S
    Kwiatkowski, C
    Psuja, P
    Lewandowski, K
    Muszynski, R
    Kicinska, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 81 (01) : 26 - 31
12345